WE’RE TAKING
NEUROLOGY
TO
A WHOLE NEW
LEVEL

Eisai Neurology is aiming to
revolutionize drug discovery and
develop targeted medicines for some
of the world’s most challenging
neurological conditions. Read how
our dedication and patient
interactions influence our approach
and help us create hope through
innovation.

WE’RE ON A MISSION TO PREVENT AND EVEN REVERSE ALZHEIMER’S DISEASE (AD)

Our 30+ year commitment to addressing AD grows naturally from our human health care mission. It’s one of society’s greatest unmet medical needs, and we’re determined to find precision solutions that go beyond treatment, to prevention and reversal. To that end, we’ve amassed an unparalleled set of capabilities:

  • We’re the only company with programs targeting amyloid (the main component of plaques found in the brains of people with AD); tau (a protein that’s vital to brain health); neurodegeneration; inflammation; and the clinical symptoms of dementia, such as cognition and sleep-wake disorders.
  • Our rich pipeline includes a wide scope of investigational compounds and diagnostic methods being researched in AD. In addition, we’re exploring novel therapies designed to address clinical symptoms such as cognition and sleep disorders.
  • Eisai and Biogen are jointly researching disease-modifying compounds* for potential treatment of AD.
  • Our ground-breaking Center for Genetics Guided Dementia Discovery (G2D2) is focused on delivering a new generation of immunodementia drugs that can bolster the body’s immunity against dementia.

We’re proud to have dedicated more than 30 years to research, development and commercialization in our relentless pursuit of treatments for Alzheimer’s
disease and dementia.”

Ivan Cheung Chairman, Eisai Inc. Global President, Neurology Business Group

DISCOVER HOW WE’RE BREAKING THROUGH
FOR PEOPLE LIVING WITH:

ONE TEAM

Looking for a team environment where you’ll be challenged to break through? Join our human health care mission to make a difference in the lives of patients.

*All compounds on this page are investigational.